Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

(TSV:MSCL)

N/A UNCHANGED
Last Price Updated: 3:08 PM EST, Feb 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MSCL

News headline image
Satellos to Commence Trading on the Toronto Stock Exchange
From Satellos Bioscience Inc.
Via Business Wire
News headline image
Satellos Announces Promising Preliminary Data in Facioscapulohumeral Muscular Dystrophy
From Satellos Bioscience Inc.
Via Business Wire
News headline image
Satellos Receives Conditional Approval to Graduate to the Toronto Stock Exchange
From Satellos Bioscience Inc.
Via Business Wire
News headline image
Satellos Bioscience Announces 2023 Q3 Financial Results and Operational Highlights
From Satellos Bioscience Inc.
Via Business Wire
News headline image
Satellos to Present at the Piper Sandler 35th Annual Healthcare Conference
From Satellos Bioscience Inc.
Via Business Wire
News headline image
Satellos Discloses Drug Target and Provides Development Update on Duchenne Muscular Dystrophy Program
From Satellos Bioscience Inc.
Via Business Wire
News headline image
Satellos to Present at the Stifel 2023 Healthcare Conference
From Satellos Bioscience Inc.
Via Business Wire
News headline image
Satellos Bioscience Inc. Announces the Appointment of Philip D. Lambert, Ph.D, as Chief Technology Officer
Toronto, Ontario--(Newsfile Corp. - September 28, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine... 
Via Newsfile
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.